Vaddi Krishna

Average Profitability
<0.0001%
Insider Buys Quantity
6
Insider Buys Sum
$274,311.49
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Vaddi Krishna

According to the SEC Form 4 filings, Vaddi Krishna, being in a position of

  1. CEO at Prelude Therapeutics Incorporated,
    оver the last 12 months, has bought 106888 shares for $99,326, and sold 0 shares,
    over all time since 2022-12-20, has bought 139832 shares for $274,311, and sold 0 shares.

The largest purchase of all time was on 2022-12-20 and amounted to 19188 shares of Prelude Therapeutics Incorporated for $98,446.

Biography of Vaddi Krishna

No biography is available at this moment.

2024-12-19PurchasePrelude Therapeutics Incorporated
PRLD
CEO
6,888
0.0122%
$0.89$6,116+30.66%
2024-12-18PurchasePrelude Therapeutics Incorporated
PRLD
CEO
100,000
0.1882%
$0.93$93,210+24.46%
2023-05-25PurchasePrelude Therapeutics Incorporated
PRLD
CEO
900
0.0019%
$5.31$4,779-27.8%
2023-05-24PurchasePrelude Therapeutics Incorporated
PRLD
CEO
1,000
0.002%
$5.01$5,011-26.36%
2023-05-23PurchasePrelude Therapeutics Incorporated
PRLD
CEO
11,856
0.0257%
$5.63$66,749-30.28%
2022-12-20PurchasePrelude Therapeutics Incorporated
PRLD
CEO
19,188
0.0417%
$5.13$98,446-6.63%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.